• To test the hypothesis that prone position ventilation, nitric oxide, and almitrine bismesylate, each acting by a different mechanism to improve arterial oxygenation, could exert additive beneficial effects when used in combination in patients with severe acute respiratory distress syndrome (ARDS). (nih.gov)
  • Inhaled nitric oxide (20 parts per million for 15 mins) in the supine and prone position, and intravenous almitrine bismesylate while prone (1 mg/kg/hr for 60 mins), alone or combined with nitric oxide. (nih.gov)
  • and i) nitric oxide and almitrine bismesylate combined, for 15 mins prone. (nih.gov)
  • 05), which was not the case when either nitric oxide or almitrine bismesylate was added separately. (nih.gov)
  • Heart rate and cardiac output were increased by almitrine bismesylate compared with all other measurements. (nih.gov)
  • In ARDS patients with severe hypoxemia, arterial oxygenation can be improved by combining the prone position, nitric oxide, and almitrine bismesylate, without deleterious effects. (nih.gov)
  • A third possibility to improve oxygenation to the blood is to stimulate the CBs with a drug such as almitrine bismesylate, which improves ventilation without central nervous system disturbances. (aspetjournals.org)
  • Ventilation was measured during normoxia, hypoxia and hypercapnia before and after administration of almitrine in conscious, unrestrained, tracheostomized rats with the superior laryngeal nerves intact or cut. (portlandpress.com)
  • BACKGROUND: Almitrine, a selective pulmonary vasoconstrictor in hypoxic area, improves oxygenation in mechanically ventilated patients with COVID-19 but its effects in spontaneously breathing patients with COVID-19 remain to be determined. (bvsalud.org)
  • The clinical efficacy of almitrine-raubasine combination therapy for age related cerebral disorders and functional rehabilitation after stroke has been reviewed by Allain and BentuĂ©-Ferrer. (wikipedia.org)
  • They summarize two studies in which almitrine-raubasine improved some symptoms significantly more than placebo, especially in vascular cases. (wikipedia.org)
  • Under the brand names Albasine, Aruxil, and Truxil, almitrine-raubasine has been marketed for rehabilitation after stroke, age related neurological disorders, visual disorders related to circulation, and tinnitus in Bangladesh. (wikipedia.org)
  • Clinical efficacy of almitrine-raubasine. (wikipedia.org)
  • Almitrine (marketed as Duxil by Servier) is a diphenylmethylpiperazine derivative classified as a respiratory stimulant by the ATC. (wikipedia.org)
  • In addition to drug discovery work, it is hoped to help support clinical trials of repurposed drugs for treatment of COVID-19, such as with Almitrine bismeylate, which is a respiratory stimulant that improves respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies and which is a lung vasoconstrictor. (ox.ac.uk)
  • The clinical trial will test if Almitrine bismeylate can enhance oxygen levels in the blood in COVID-19 patients in order to improve their clinical outcome. (ox.ac.uk)
  • Almitrine is a drug used in the treatment of hypoxemic chronic lung diseases such as bronchitis and emphysema because it is a potent stimulant of the carotid bodies in human and different animal species that produces a long-lasting enhancement of alveolar ventilation, ameliorating arterial blood gases. (aspetjournals.org)
  • However, this concentration of almitrine significantly inhibited the Ca 2+ -dependent component of K + currents in rat chemoreceptor cells. (aspetjournals.org)
  • Internationally, almitrine were at least nine placebo managed studies on the treating cardiovascular disease with CoQ10 two in Japan, two in america, two in Italy, two in Germany, and one in Sweden. (clair-environnement.eu)
  • However, the mechanism of action of almitrine remains unknown. (aspetjournals.org)
  • We conclude that almitrine inhibits selectively the Ca 2+ -dependent K + channel and that in rat chemoreceptor cells, this inhibition could represent an important mechanism of action underlying the therapeutic actions of the drug. (aspetjournals.org)
  • CONCLUSIONS: Almitrine could be an interesting therapy in spontaneously breathing patients with COVID-19 treated with HFNO and with persistent hypoxemia, given its effects on oxygenation without serious adverse effects regardless of the CT-Scan pattern, and potentially on intubation rate. (bvsalud.org)
  • We investigated the effect of almitrine on ionic currents of chemoreceptor cells isolated from the carotid body of rat and rabbits by using the whole-cell and inside-out configurations of the patch-clamp technique. (aspetjournals.org)
  • This effect of almitrine on the Ca 2+ -dependent component of K + currents was investigated further at the single-channel level in excised patches in the inside-out configuration. (aspetjournals.org)
  • The inhibitory effect of almitrine on Ca 2+ -dependent K + channels also was observed in GH3 cells. (aspetjournals.org)
  • Intravenous almitrine, which augments hypoxic pulmonary vasoconstriction, is used for short-term improvement of arterial oxygenation. (silverchair.com)
  • or = 150 mmHg) who where treated with intravenous almitrine. (silverchair.com)
  • Intravenous almitrine increased the ratio of arterial oxygen pressure to inspiratory oxygen fraction from 93 +/- 33 mmHg to 207 +/- 107 mmHg (mean +/- SD). (silverchair.com)
  • Therefore, intravenous almitrine was discontinued. (silverchair.com)
  • This study confirms that intravenous almitrine greatly improves arterial oxygenation in patients with acute lung injury but may also induce lactic acidosis and hepatic dysfunction. (silverchair.com)
  • The coexistence of lactic acidosis and hepatic dysfunction in the same patients strongly suggests that the liver is the primary source of intravenous almitrine-induced lactic acidosis. (silverchair.com)
  • Combinations of inhaled NO with various therapies, such as the use of intravenous almitrine or phenylephrine, and prone positioning may produce additive effects on oxygenation. (accjournal.org)
  • Almitrine, a selective pulmonary vasoconstrictor in hypoxic area, improves oxygenation in mechanically ventilated patients with COVID-19 but its effects in spontaneously breathing patients with COVID-19 remain to be determined. (biomedcentral.com)
  • Almitrine (marketed as Duxil by Servier) is a diphenylmethylpiperazine derivative classified as a respiratory stimulant by the ATC. (wikipedia.org)
  • Almitrine could be an interesting therapy in spontaneously breathing patients with COVID-19 treated with HFNO and with persistent hypoxemia, given its effects on oxygenation without serious adverse effects regardless of the CT-Scan pattern, and potentially on intubation rate. (biomedcentral.com)
  • The first aim of this study was to assess the effects of almitrine on oxygenation in spontaneously breathing patients with severe pneumonia related to SARS-CoV-2 pneumonia treated with high-flow nasal cannula oxygen therapy (HFNO) and with persistent hypoxemia. (biomedcentral.com)
  • The second aim was to assess the effects of almitrine on oxygenation according to the thoracic CT-Scan patterns. (biomedcentral.com)
  • Univariate and multivariate analyses revealed that an abnormal plasma concentration of total bilirubin before almitrine administration and female gender were the two factors significantly linked with lactic acidosis during almitrine infusion. (silverchair.com)
  • The National Agency for the Safety of Medicine and Health Products (ANSM), which regulates drugs in France, asked PRAC to review almitrine in light of weight loss and neuropathy experienced by some patients, according to the EMA. (medscape.com)
  • We included all patients over 18 years old admitted to ICU for SARS-CoV-2 pneumonia treated with HFNO and with persistent hypoxemia from January 2021 (start of the use of almitrine in our ICU for patients with COVID-19) to January 2022. (biomedcentral.com)
  • In this group of patients, the total bilirubin concentration was elevated before almitrine administration, and the results of other hepatic function tests, such as aspartate aminotransferase, alanine aminotransferase, and prothrombin time, were altered by almitrine administration. (silverchair.com)
  • 31. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? (nih.gov)
  • French regulators also noted that "the available evidence does not support a role for almitrine as part of current management of COPD as its benefit is unclear and alternative treatments are available. (medscape.com)